Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes.

Journal Information

Full Title: Curr Atheroscler Rep

Abbreviation: Curr Atheroscler Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing InterestsConflicts of Interest: Professor Wilding reports grants and personal fees from AstraZeneca; personal fees and consultancy fees paid to his institution from Boehringer Ingelheim; grants; personal fees and consultancy paid to his institution from Novo Nordisk; consultancy fees paid to his institution from Altimmune, Eli Lilly, Menarini, Napp, Pfizer, Rhythm Pharmaceuticals, Saniona, Tern, Shionogi, and Ysopia, outside the submitted work. Dr. Zhu reports no conflict of interest. Human and Animal RightsAll reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines). Competing Interests Conflicts of Interest: Professor Wilding reports grants and personal fees from AstraZeneca; personal fees and consultancy fees paid to his institution from Boehringer Ingelheim; grants; personal fees and consultancy paid to his institution from Novo Nordisk; consultancy fees paid to his institution from Altimmune, Eli Lilly, Menarini, Napp, Pfizer, Rhythm Pharmaceuticals, Saniona, Tern, Shionogi, and Ysopia, outside the submitted work. Dr. Zhu reports no conflict of interest."

Evidence found in paper:

"Funding Dr. Zhu reports grants from The China Scholarship Council (grant number: 202006920018), The Second Affiliated Hospital of Soochow University (grant number: SDFEYBS1815), and The Jiangsu Innovation & Career Fund for PhD 2019, for supporting the conduct of the study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025